IP Verse

A Method Of Controlling The Release Of An Active Ingredient From A Dosage Form - EP2598121

The patent EP2598121 was granted to DOW on Aug 8, 2018. The application was originally filed on Jun 9, 2011 under application number EP11726026A. The patent is currently recorded with a legal status of "Revoked".

EP2598121

DOW
Application Number
EP11726026A
Filing Date
Jun 9, 2011
Status
Revoked
Jul 10, 2020
Grant Date
Aug 8, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

TYLOSE & COKGMay 8, 2019PLATEADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP0954536
DESCRIPTIONEP1127895
DESCRIPTIONEP1127910
DESCRIPTIONUS4734285
DESCRIPTIONUS6320043
DESCRIPTIONUS6509461
INTERNATIONAL-SEARCH-REPORTUS2001034441
INTERNATIONAL-SEARCH-REPORTUS4979681
INTERNATIONAL-SEARCH-REPORTWO0035295
INTERNATIONAL-SEARCH-REPORTWO0219990
OPPOSITIONDE4414544
OPPOSITIONEP0370447
OPPOSITIONUS4389393
OPPOSITIONUS6509461
OPPOSITIONWO2008122345

Non-Patent Literature (NPL) Citations (4) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- "METOLOSE SR Sustained Release Agent for Matrix System", ShinEtsu, (20040000), pages 1 - 17, XP055590563-
OPPOSITION- ShinEtsu, "METOLOSE SR Sustained Release Agent for Matrix System", ShinEtsu, (20040000), pages 1 - 17, XP055590563-
OPPOSITION- "Using METHOCEL Cellulose Ethers for Controlled Release of Drugs in Hydrophilic Matrix System", DOW Chemical Co., USA, (20000700), pages 1 - 36, XP002693777-
OPPOSITION- "Using METHOCEL Cellulose Ethers for Controlled Release of Drugs in Hydrophilic Matrix System", DOW, USA, (20000700), XP002693777-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents